Multiple biomarkers for risk prediction in chronic heart failure.

Circulation. Heart Failure
Bonnie KyThomas P Cappola

Abstract

Prior studies have suggested using a panel of biomarkers that measure diverse biological processes as a prognostic tool in chronic heart failure. Whether this approach improves risk prediction beyond clinical evaluation is unknown. In a multicenter cohort of 1513 chronic systolic heart failure patients, we measured a contemporary biomarker panel consisting of high-sensitivity C-reactive protein, myeloperoxidase, B-type natriuretic peptide, soluble fms-like tyrosine kinase receptor-1, troponin I, soluble toll-like receptor-2, creatinine, and uric acid. From this panel, we calculated a parsimonious multimarker score and assessed its performance in predicting risk of death, cardiac transplantation, or ventricular assist device placement in comparison to an established clinical risk score, the Seattle Heart Failure Model (SHFM). During a median follow-up of 2.5 years, there were 317 outcomes: 187 patients died; 99 were transplanted; and 31 had a ventricular assist device placed. In unadjusted Cox models, patients in the highest tertile of the multimarker score had a 13.7-fold increased risk of adverse outcomes compared with the lowest tertile (95% confidence interval, 8.75-21.5). These effects were independent of the SHFM (adjusted...Continue Reading

References

Sep 4, 2003·Circulation·Stephan BaldusUNKNOWN CAPTURE Investigators
Jan 13, 2006·Circulation·Thomas ThomUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Mar 15, 2006·Circulation·Wayne C LevyMilton Packer
Sep 5, 2006·The American Journal of Cardiology·W H Wilson TangStanley L Hazen
Dec 22, 2006·The New England Journal of Medicine·Thomas J WangRamachandran S Vasan
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
May 16, 2008·The New England Journal of Medicine·Björn ZetheliusJohan Arnlöv
May 16, 2008·The New England Journal of Medicine·W Frank PeacockUNKNOWN ADHERE Investigators
May 16, 2008·The New England Journal of Medicine·Eugene Braunwald
Oct 2, 2008·Nature Reviews. Drug Discovery·Rahul Kakkar, Richard T Lee
Jan 24, 2009·Journal of the American College of Cardiology·Andreas P KalogeropoulosJaved Butler
Jan 28, 2009·Circulation·Donald Lloyd-JonesUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Mar 31, 2009·Journal of Cardiac Failure·José Paulo AraújoPaulo Bettencourt
Jul 2, 2009·JAMA : the Journal of the American Medical Association·Olle MelanderThomas J Wang
Jul 28, 2009·Heart Failure Clinics·A Mark Richards
Jul 28, 2009·Heart Failure Clinics·Sachin GuptaJames A de Lemos
Aug 4, 2009·European Journal of Heart Failure·Rudolf A de BoerDirk J van Veldhuisen
Aug 28, 2009·The New England Journal of Medicine·Tobias ReichlinChristian Mueller
Feb 4, 2010·Annals of Internal Medicine·Ewout W Steyerberg, Michael J Pencina
Mar 11, 2010·European Journal of Heart Failure·Stephan von HaehlingStefan D Anker
May 8, 2010·Journal of the American College of Cardiology·Jay N Cohn
Sep 25, 2010·Journal of the American College of Cardiology·Robb D KociolG Michael Felker
Oct 13, 2010·Circulation·Raghava S VelagaletiRamachandran S Vasan
Dec 24, 2010·Circulation. Heart Failure·Bonnie KyThomas P Cappola
Jan 21, 2011·Proceedings of the National Academy of Sciences of the United States of America·Thomas P CappolaGerald W Dorn
Jan 29, 2011·Congestive Heart Failure·Leonardo TamarizJoshua Hare
Jun 3, 2011·JAMA : the Journal of the American Medical Association·John P A Ioannidis, Orestis A Panagiotou
Jun 3, 2011·JAMA : the Journal of the American Medical Association·Patrick M M Bossuyt

❮ Previous
Next ❯

Citations

Apr 24, 2013·Journal of Cardiovascular Translational Research·Deepa M Gopal, Flora Sam
May 15, 2013·Journal of Cardiovascular Translational Research·Justin Hartupee, Douglas L Mann
Jan 31, 2014·Current Heart Failure Reports·Erik Tandberg AskevoldPål Aukrust
May 7, 2014·Biomarkers in Medicine·Irene SanchezLuis Manzano
Jun 15, 2014·Journal of Cardiac Failure·Esther VorovichThomas P Cappola
Jun 16, 2014·JACC. Heart Failure·Tariq AhmadJames L Januzzi
Oct 11, 2014·Future Cardiology·Lori B Daniels, Antoni Bayes-Genis
Jan 15, 2014·Critical Reviews in Clinical Laboratory Sciences·Giuseppe Lippi, Gianfranco Cervellin
Aug 25, 2015·Revista Española De Cardiología·Antoni Bayes-GenisJosep Lupón
Dec 18, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Marco Matteo CicconePietro Scicchitano
May 20, 2015·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·W van BoxtelH W M van Laarhoven
Aug 19, 2014·International Journal of Cardiology·David M KayeMicha T Maeder
Mar 4, 2014·Indian Heart Journal·I SatyamurthyAlan S Maisel
Mar 4, 2015·International Journal of Cardiology·Josep LupónAntoni Bayes-Genis
Mar 10, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·William L HolmanRenzo Y Loyaga-Rendon
Feb 18, 2014·Journal of Cardiac Failure·Andreas P KalogeropoulosJaved Butler
Nov 30, 2013·Cardiology Clinics·Frances L Johnson
Jun 8, 2013·Journal of Cardiac Failure·Michael M GivertzRandall C Starling
Mar 5, 2013·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Christopher AdlbrechtRichard Pacher
Mar 30, 2016·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Omar F AbouEzzeddineMargaret M Redfield
Jul 25, 2012·Progress in Cardiovascular Diseases·Andreas P KalogeropoulosJaved Butler
Jul 25, 2012·Progress in Cardiovascular Diseases·Dawn M PedrottyThomas P Cappola
Nov 17, 2015·Journal of Cardiac Failure·Benjamin FrenchThomas P Cappola
May 8, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Kenjiro SatoUNKNOWN CHART-2 Investigators
Sep 18, 2015·European Journal of Heart Failure·Eugene Braunwald
Jan 3, 2013·Congestive Heart Failure·Andreas P KalogeropoulosJaved Butler
Oct 10, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Francesca De IuliisSusanna Scarpa
Aug 19, 2015·Current Heart Failure Reports·Parul U GandhiTariq Ahmad
Mar 3, 2015·Journal of Cardiac Failure·Ruth M Masterson CreberBarbara Riegel
Feb 24, 2015·The American Journal of Cardiology·Thomas Mueller, Allan S Jaffe
Feb 24, 2015·The American Journal of Cardiology·Antoni Bayes-GenisBonnie Ky
Oct 1, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Benjamin Dieplinger, Thomas Mueller
Dec 3, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Antoni Bayes-Genis, Jordi Ordonez-Llanos
Dec 3, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Anne-Catherine Pouleur
Mar 14, 2014·JACC. Heart Failure·Eugene Braunwald
Oct 26, 2016·Frontiers in Cardiovascular Medicine·Antoni Bayes-GenisJosep Lupón Rosés
Jun 28, 2013·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Ahmet KayaIbrahim Halil Tanboga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.